ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $268,000 | -22.1% | 8,044 | -38.1% | 0.19% | -24.5% |
| Q2 2020 | $344,000 | -9.5% | 12,987 | -44.0% | 0.25% | -25.9% |
| Q1 2020 | $380,000 | -2.1% | 23,198 | +52.0% | 0.34% | -2.0% |
| Q4 2019 | $388,000 | +25.2% | 15,259 | -1.5% | 0.34% | +12.5% |
| Q3 2019 | $310,000 | -33.5% | 15,498 | +7.2% | 0.30% | -28.1% |
| Q2 2019 | $466,000 | -4.9% | 14,462 | -4.8% | 0.42% | -17.7% |
| Q1 2019 | $490,000 | +36.1% | 15,198 | +3.4% | 0.52% | +35.5% |
| Q4 2018 | $360,000 | – | 14,692 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |